iNtRON Biotechnology Inc operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares iNtRON Biotechnology Inc with three other
companies in this sector in South Korea:
sales of 18.70 billion Korean Won [US$15.69 million]
of which 78%
was Other Segment),
Daesung Microbiological Labs. Co., Limited
(25.10 billion Korean Won [US$21.06 million]
Chem Tech Research Inc
(20.54 billion Korean Won [US$17.23 million]
of which 26%
was OTC entrusted).
iNtRON Biotechnology Inc reported sales of 20.58 billion Korean Won (US$17.27 million)
December of 2018.
increase of 87.8%
versus 2017, when the company's sales were 10.96 billion Korean Won.